SURMOUNT-1 tested tirzepatide - the dual GIP/GLP-1 receptor agonist
Early-phase data have suggested potential benefits in conditions such as hepatic steatosis (fatty liver disease) and dyslipidaemia, which frequently accompany obesity
The rationale of this review is to empower GPs in managing HS, considering the anticipated increase in biologic treatment availability for HS
GLP-1 has a variety of effects, originating from the presence of its receptors in specific nuclei of the lung, pancreas, gastrointestinal tract, kidney, heart, bone, central nervous system, etc
Uses of GLUTONE INJECTION 1 are: Liver Disorders: Helps manage glutathione deficiency in various liver disorders
Your PlexusDx provider evaluates your surgical history, current symptoms, and metabolic profile to recommend the best fit